Market Place
Sourcing Support
All News #Library
Others
Hugel Boosts Global Value Creation Through U.S.-Led Growth
15 Jan 2026 //
PR NEWSWIRE
Hugel Receives FDA Approval in the United States of Letybo for Injection
04 Mar 2024 //
PR NEWSWIRE
Hugel`s `Letybo` First in Korea to Obtain Marketing Approval from Australia
24 Nov 2022 //
PRNEWSWIRE
Hugel resubmits BLA for botulinum toxin, Botulax to US FDA
08 Oct 2022 //
PHARMABIZ
Hugel Achieves Record-High Performance for 2Q…Revenue of KRW67.4bn
10 Aug 2022 //
PRESS RELEASE
Recent publication confirms the efficacy and safety of LetibotulinumtoxinA i
26 Jul 2022 //
PRESS RELEASE
Hugel accelerates the leap forward as a global company
19 May 2022 //
PRESS RELEASE
Hugel America Announces U.S. FDA Acceptance of BLA for LetibotulinumtoxinA
15 Jun 2021 //
PRNEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.